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Pathophysiology
o The classic description is 
progressive “biphasic” effect on the 
CNS then to the CVS
o CNS excitation progresses to 
seizure or CNS depression. This is 
followed by CVS excitation 
(tachycardia or ventricular 
arrhythmia) then depression 
(bradycardia or asystole) 
(Ciechanowicz & Patil, 2012).
o Cardiovascular system toxicity is 
classically three phases
o Initial phase: hypertension and 
tachycardia
o Intermediate: myocardial 
depression and hypotension
o Terminal: peripheral vasodilation, 
severe hypotension and 
arrhythmias (bradycardia, 
conduction blocks or asystole) 
(Christie, Picard & Weinberg, 
2015).
o Early: metallic taste, auditory 
changes, visual disturbance (mainly 
focusing), lightheadedness, 
apprehension, drowsiness and 
numbness of tongue and lips; 
Restlessness, agitation, myoclonus, 
nystagmus and slurred speech 
occur at high doses 
o The early signs are caused by 
blocking inhibitory pathways in 
cerebral cortex- which allows for 
disinhibition of facilitator neurons 
resulting in excitatory cell 
dominance causing dizziness or 
lightheadedness (Dewaele & Santos, 
2013). 
o Tachycardia and hypertension can 
occur after injection without 
epinephrine (Weinburg, 2002). 
o Cardiovascular manifestations: 
Dysrhythmias and conduction 
delays (from prolonger PR interval 
to asystole), chest pain, shortness 
of breath, palpitations, 
lightheadedness, diaphoresis, 
hypotension, and syncope
o Local anesthesia (LA) provides a 
way to relieve temporary pain in a 
small part of the body and has been 
used for over 100 years (Fencl, 
2015).
o LA prevents the passage of surgical 
stimuli into the central nervous 
system (CNS) making a surgical 
procedure less painful for the 
patient (Noble, 2015).
o According to Noble, “altering the 
passage of stimuli from smaller 
diameter neurons in a confined area 
with lower drug dosages is called 
LA, such as the injection of LA 
around a surgical incision” (Noble, 
2015, p.325). 
o When performing LA 
administration one must be aware 
of the risk of local anesthetic 
systemic toxicity (LAST) (Fencl, 
2015).  
o It is a very serious and sometimes 
fatal complication to 
administration. It can result from 
the patient’s risk factors, current 
medications or inadvertent injection 
directly into the vascular system-
resulting in immediate absorption 
of the anesthetic agent into an 
exceptionally vascular area (Fencl, 
2015).  
o According to Stannard (2015), 20 
out of 10,000 peripheral nerve 
blocks (PNBs) and 4 per 10,000 
epidurals result in LAST. 
o PNBs improve short-term pain 
control, lowers pain scores from0-
72 hours post procedure and 
reduces hospital length of stay 
(Joshi, Gandhi, Shah, Gadsden, & 
Corman, 2016).
o Early response at the first sign of 
toxicity is pertinent and improves 
chances of successful treatment.  
Once the reaction is noticed, 
immediate supportive care needs to 
be initiated due to the chance of 
severe cardiac depression.  
Advanced Cardiac Life Support 
(ACLS) should be started 
immediately and is considered the 
first-line treatment for this 
complication (Noble, 2015).  
o Systemic toxicity from local 
anesthetic (LA) occurs due to 
accidental intravascular injection, 
absorption from the tissues or 
repeated doses without balanced 
elimination 
o The pathophysiology of LAs are 
thought to be an extension of their 
uses.
o Blocking cardiac voltage-gated 
sodium channels, prevention myocyte 
depolarization, blocking 
repolarization via potassium 
channels and blocking sarcoplasmic 
reticulum voltage-dependent calcium 
channels to limit the increase of 
calcium available for contraction 
(Ciechanowicz & Patil, 2012).
o Myocyte ATP is reduced which limits 
energy available for connecting actin-
myosin cycle and ion channel 
involvement is extensive 
(Ciechanowicz & Patil, 2012).
o Bupivacaine, Levobupivacaine and 
Ropivacaine are long acting amide-
based LA most commonly used in 
clinical practice (Ciechanowicz & 
Patil, 2012).
o LAs rapidly cross cell membranes 
and toxicity can act in many sites 
including ionotropic and 
metabotropic. 
o In the brain, LA affects inhibitory and 
excitatory pathways
o In the heart, LAs can cause 
conduction blocks through sodium, 
potassium and calcium channels-
resulting in dysrhythmias and 
reduced contractility (Christie, Picard 
& Weinberg, 2015).
o LA can disrupt intracellular signal 
originating at metabotropic 
receptors- leading to reduced 
monophosphate concentrations and 
decreased contractility.
o In addition, the heart has preference 
for fats and ketone bodies. To be 
oxidized, the fats must be carried 
across the mitochondrial membranes 
by a translocase system which is 
inhibited by concentrations of LA 
leading to enhanced potency 
(Christie, Picard & Weinberg, 2015).
o LAST can be fatal if it is not 
recognized early enough!
o A checklist was developed by the 
American Society of Regional 
Anesthesia and Pain Medicine 
(ASRA) for the management of LAST 
(Neal et al., 2012).
o Stage 1: Get help
o Stage 2: Initial Focus
o Airway management: 
ventilate with 100% 
oxygen
o Seizure management: 
benzodiazepines 
preferred. AVOID 
Propofol in patients 
with cardiovascular 
instability 
o Stage 3: Cardiac Arrhythmia 
Management
o Initiate ACLS if 
needed 
o Avoid vasopressin, 
calcium channel 
blockers, beta 
blockers or LA
o Reduce epinephrine 
does to < 1mcg/kg
Nursing Implication
o Stage 4: Lipid Emulsion Management
o Bolus 1.5 ml/kg IV over 
2 minutes
o Continuous infusion 
o May repeat bolus
o The lipid emulsion creates a lipid 
phase that extracts the lipid soluble 
molecules from the plasma phase 
decreasing toxicity and potentially 
reversing LAST (Nicholas & Thornton, 
2016). 
o Stage 5: Stabilization
o ASRA concludes:
Be prepared
Risk reduction
Detection
Treatment (Neal et al., 2012). 
o See Table 1
o When the effectiveness of the checklist was researched by Neal et al. (2012), 
results showed improved outcomes and excellent medical management of 
LAST.  
o Prevention measures (in a checklist form) have been put in place to help 
reduce the risk of LAST by The American Society of Regional Anesthesia and 
Pain Management (ASRA) 
o This is a helpful tool utilized by anesthesia staff to help focus on the immediate 
needs of the patient and manage cardiac events for someone diagnosed with 
LAST.  
o By educating all staff, effective management of this emergent situation will 
help influence a positive patient outcome.  
o Comprehensive training on LAST guidelines and treatment, along with best 
practice measures for patients receiving LA are essential for optimistic patient 
outcomes.  
Table 1.  Checklist created by ASRA. Image provided by Neal, Mulroy & Weinberg, 
2012. 
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